Patents Issued in April 2, 2020
-
Publication number: 20200101266Abstract: An improved catheter insertion assembly having a transparent tubular member open at each end; a plunger assembly slidable within the tubular member having a stem portion at a first end; and at least a partially transparent chamber having a needle base and sealing member on a second end of the plunger assembly; an elongated tubular needle embedded within the needle base and extending there from with the needle in fluid communication with the transparent chamber; a catheter assembly, a transparent cannula and a transparent hub attached to the second end with the tubular needle passing longitudinally through the cannula; a fluid passage formed between the needle and the cannula so that when the plunger is retracted a vacuum is established within the fluid passage and blood is visibly drawn through the fluid passage into the transparent cannula and if volume permits, blood then would be visible in the transparent hub, and then if volume permits blood would be visible in the void of the catheter body (barrel) creaType: ApplicationFiled: September 30, 2019Publication date: April 2, 2020Inventor: Toby Wexler
-
Publication number: 20200101267Abstract: Three groups of guidewire embodiments are described with particularly suitable structures for navigating circuitous vessels, especially blood vessels of the brain. Some of the guidewires have a hyperbolic taper that provides desired flexibility. In some embodiments, an integrated guide structure provides for extension in the blood vessel of a corewire to provide for extended reach of the guidewire. In further embodiments, the guidewire has a flexible tip that can be guided directly by the flow in the vessel.Type: ApplicationFiled: November 20, 2019Publication date: April 2, 2020Inventors: James Pokorney, Matthew F. Ogle
-
Publication number: 20200101268Abstract: Embodiments hereof relate to methods of delivering a valve prosthesis to an annulus of a native valve of a heart, the native valve having chordae tendineae. A chordae management catheter is positioned within a ventricle of the heart, the chordae management catheter having a displacement component at a distal end thereof. The displacement component has an annular shape and defines a central lumen therethrough. The displacement component is radially expanded to push chordae tendineae within the ventricle radially outward. A valve delivery system is introduced into the ventricle of the heart via a ventricular wall of the heart. The valve delivery system has the valve prosthesis at a distal portion thereof. The valve delivery system is advanced through the central lumen of the radially expanded displacement component towards the annulus of the native valve of the heart. The valve prosthesis is deployed into apposition with the annulus of the native valve.Type: ApplicationFiled: November 27, 2019Publication date: April 2, 2020Inventors: Paul DEVEREUX, Paraic FRISBY, Frank WHITE, Tomas KITT, Marc ANDERSON, Grainne CARROLL, Ciaran MCGUINNESS, Tim JONES, Patrick GRIFFIN
-
Publication number: 20200101269Abstract: An apparatus and methods to form a tissue scaffolding are provided. The apparatus may include a catheter shaft extending from a proximal end to a distal tip, a distal balloon positioned on the catheter shaft proximal to the distal tip, and a proximal balloon positioned on the catheter shaft proximal to the distal balloon. The apparatus may further include an intermediate balloon positioned on a distal segment of the catheter shaft proximal to the distal balloon and distal to the proximal balloon. The intermediate balloon and the distal segment each include a translucent material. A light fiber may extend through the distal segment. A first lumen and a second lumen may be arranged in the catheter shaft, the first lumen comprising a first port located between the distal balloon and the intermediate balloon, and the second lumen comprising a second port located between the intermediate balloon and the proximal balloon.Type: ApplicationFiled: October 2, 2018Publication date: April 2, 2020Inventors: RB Eugene HAYES, D H. PERKINS, Jie REN, Robert R. SCOTT
-
Publication number: 20200101270Abstract: Devices and methods for increasing a patient's pulmonary arterial compliance are disclosed. The devices include catheters designed to create a connection between a patient's venous anatomy and the patient's pulmonary artery. With the arteriovenous connection various devices can be implanted in order to increase the volumetric compliance of the pulmonary artery. The devices include collapsible and expandable mechanisms which allow the effective pulmonary arterial volume to expand during systole and contract during diastole. The devices may include a balloon or balloon-like implants which cyclically shuttle a working fluid from the pulmonary artery to the vein and back. The devices may be adjustable to provide desired hemodynamic benefits. Methods are disclosed for making and using the inventive devices.Type: ApplicationFiled: September 23, 2019Publication date: April 2, 2020Inventor: Michael Warren Sutherland
-
Publication number: 20200101271Abstract: An expandable dilation member may include a proximally-tapered portion to dilate a stricture. The dilation member may be distally advanced in an unexpanded state over a wire guide through the stricture. The dilation member may then be configured in an expanded state, where the dilation member has a longitudinal profile that includes the proximally-tapered portion. A handle assembly proximally pulls the dilation member in the expanded state. In response, the proximally-tapered portion engages with and biases the stricture. When biasing the stricture, the proximally-tapered portion exerts a plurality of different types of forces, including a shearing force, a radial force, and in some procedures, a torsional force. In some embodiments, the proximally-tapered portion has a continuous taper from a smallest diameter to a largest diameter. In other embodiments, the proximally-tapered portion has at least one constant-diameter portion longitudinally disposed in between the smallest diameter and the largest diameter.Type: ApplicationFiled: September 30, 2019Publication date: April 2, 2020Applicant: Cook Medical Technologies LLCInventors: John Crowder Sigmon, JR., Shaun D. Gittard, Gregory J. Hardy, Vihar Surti
-
Publication number: 20200101272Abstract: An intra-tumoral agent deployment apparatus for diagnosing and delivering targeted, sequential deployment of agents to an endo-bronchial and, or an intra-parenchymal tumor, said apparatus formed of, among other things, an elongated shaft assembly including: at least one lumen; an intra-tumoral probe wire for tumor traversal, slidably interposed there between or slidably disposed between any one of, or combination of the at least one lumen; and wherein the displacement of the intra-tumoral probe wire causes disruption of an endo-bronchial and, or an intra-parenchymal tumor tissue, and, or creating an inlet for deployment of at least a first agent comprising any one of a therapeutic agent and, or a delivery vehicle from the first lumen, and a subsequent second agent comprising any one of a therapeutic agent and, or a binding agent from any one of the first lumen, second lumen, and, or the delivery vehicle.Type: ApplicationFiled: October 29, 2016Publication date: April 2, 2020Inventor: Stephen Kuperberg
-
Publication number: 20200101273Abstract: Provided herein is a delivery system, including: (a) an optical sensor configured to detect data useful to create a map of a bodily surface; and (b) a printer operatively associated with the optical sensor and configured to deliver compositions (optionally including cells) to the bodily surface based upon the data or map. Methods of forming a tissue on a bodily surface of a patient in need thereof are also provided, as are methods, systems and computer program products useful for processing bodily surface data.Type: ApplicationFiled: November 25, 2019Publication date: April 2, 2020Inventors: James J. Yoo, Anthony Atala, Kyle W. Binder, Weixin Zhao, Dennis Dice, Tao Xu
-
Publication number: 20200101274Abstract: Provided are a method of applying a microneedle array, and a patch or an assistant tool used therefor. When skin is to be stretched and punctured with microneedles, the microneedle array can be prevented from detaching from the skin by providing adhesive layers, with the microneedle array therebetween, in a direction different from the direction in which the skin is stretched. Additionally, the application method can be appropriately implemented by producing a patch or an assistant tool having a rigid flat plate. As a result, the microneedle array can be punctured more accurately with less stress.Type: ApplicationFiled: December 11, 2017Publication date: April 2, 2020Inventors: Katsunori KOBAYASHI, Hidetoshi HAMAMOTO
-
Publication number: 20200101275Abstract: Systems and methods for delivering a drug or other therapy over an extended period of time (e.g., several hours, days, weeks, months, years, and so forth) are disclosed herein, as are systems and methods for monitoring various parameters associated with the treatment of a patient. Systems and methods are also disclosed herein that generally involve CED devices with various features for reducing or preventing backflow.Type: ApplicationFiled: September 13, 2019Publication date: April 2, 2020Applicant: Alcyone Lifesciences, Inc.Inventors: Deep Arjun Singh, PJ Anand, Andrew East
-
Publication number: 20200101276Abstract: A tube-docking holding device includes a first connector bracket and a second connector bracket. The first connector bracket includes two shells. When the two shells are closed, a first accommodation space is surrounded for fixing a portion of a first connector assembly of a catheter. The second connector bracket includes a base body and a cover body. The base body includes a first inner shell and a first outer shell. The cover body includes a second inner shell and a second outer shell. When the cover body and the base body are closed, the first inner shell and the second inner shell surround and define a second accommodation space for fixing a portion of a second connector assembly of a dialysate tube. An interconnected guiding space is formed between the first inner shell and the first outer shell and between the second inner shell and the second outer shell.Type: ApplicationFiled: October 1, 2018Publication date: April 2, 2020Inventor: Sung-An Lin
-
Publication number: 20200101277Abstract: An architecture is disclosed for an Implantable Pulse Generator having improved compliance voltage monitoring and adjustment software and hardware. Software specifies which stimulation pulses are to be measured as relevant to monitoring and adjusting the compliance voltage. Preferably, specifying such pulses occurs by setting a compliance monitoring instruction (e.g., a bit) in the program that defines the pulse, and the compliance monitor bit instruction may be set at a memory location defining a particular pulse phase during which the compliance voltage should be monitored. When a compliance monitor instruction issues, the active electrode node voltages are monitored and compared to desired ranges to determine whether they are high or low. Compliance logic operates on these high/low signals and processes them to decide whether to issue a compliance voltage interrupt to the microcontroller, which can then command the compliance voltage generator to increase or decrease the compliance voltage.Type: ApplicationFiled: December 3, 2019Publication date: April 2, 2020Inventors: Emanuel Feldman, Goran N. Marnfeldt, Kenneth Hermann
-
Publication number: 20200101278Abstract: A patient-worn arrhythmia monitoring and treatment device weight between 250 grams and 2,500 grams includes at least one contoured pad configured to be adhesively coupled to a patient's torso, a plurality of therapy electrodes, at least one of which is integrated with the at least one contoured pad, and a plurality of ECG sensing electrodes, at least one of which is integrated with the at least one contoured pad. At least one housing configured to form a watertight seal with the at least one contoured pad extends no more than 5 cm from the contoured pad. A processor disposed within the housing is coupled to a therapy delivery circuit and configured to detect one or more treatable arrhythmias based on at least one ECG signal and cause a therapy delivery circuit to deliver at least one defibrillation pulse on detecting the one or more treatable arrhythmias.Type: ApplicationFiled: September 27, 2019Publication date: April 2, 2020Inventors: Gary A. Freeman, James A. Patterson, III
-
Publication number: 20200101279Abstract: A device for delivering an implantable medical device (IMD) includes an elongated member and a deployment bay configured to house the IMD, the deployment bay defining a distal opening for deploying the IMD out of the deployment bay. The device includes a first electrode located inside the deployment bay during intravascular navigation, a second electrode, and impedance detection circuitry configured to deliver an electrical signal to a path between the first electrode and the second electrode through at least one of a fluid or tissue of the patient. The device also includes processing circuitry configured to determine an impedance of the path based on the signal and control a user interface to indicate when an impedance of the path indicates that at least one of the IMD or the distal opening is in a fixation configuration relative to the target site of the patient.Type: ApplicationFiled: September 28, 2018Publication date: April 2, 2020Inventors: Ronald A. Drake, Kathryn Hilpisch, Kevin R. Seifert, William Schindeldecker, Stephanie Koppes, Brian P. Colin, Alexander R. Mattson
-
Publication number: 20200101280Abstract: An apparatus for the treatment of urinary incontinence includes a balloon configured for movement between an inflated state and a deflated state, and the balloon includes bellows. An electrode is coupled to an outer surface of the balloon, and is configured to transmit an electrical pulse to cause a contraction of a muscle in communication with the electrode. A control device is configured to be operable by a user to cause the balloon to selectively move between the inflated state and the deflated state and to cause the electrode to transmit the electrical pulse. The bellows and the electrode are configured to cooperate to maintain the structural integrity of the balloon. The bellows and the electrode are further configured to cooperate to cause the balloon to inflate in a radially non-uniform manner.Type: ApplicationFiled: September 28, 2018Publication date: April 2, 2020Applicant: INCONTROL MEDICAL, LLCInventor: Herschel Peddicord
-
Publication number: 20200101281Abstract: A low-profile intercranial device with universal power supply includes a static cranial implant adapted for the selective integration of a functional neurological implant. It also includes a universal power supply having a universal implantable power source with a connector.Type: ApplicationFiled: October 2, 2019Publication date: April 2, 2020Inventors: Chad R. Gordon, Jesse Christopher, Corbin Clawson, Jimmy Shah
-
Publication number: 20200101282Abstract: According to an embodiment, a system for acquiring ECAP recordings at a later session for a cochlear implant patient is disclosed. The system includes a receiving unit configured to receive, corresponding to an electrode, a stored prior individual value from a plurality of stored prior individual values of ECAP/an ECAP prior growth function, the plurality of stored prior individual values or the ECAP prior growth function being obtained at a previous session. Furthermore, a processing unit configured to process the received prior individual value/ECAP growth function to determine a stimulus signal value corresponding to the received individual value/a selected point on the ECAP prior growth function, instruct a signal delivery unit to provide to the electrode a first stimulus signal comprising a first level that is same or above said stimulus signal value, and determine a resulting ECAP generated in response to said first stimulus signal.Type: ApplicationFiled: December 3, 2019Publication date: April 2, 2020Applicant: Oticon Medical A/SInventor: Edward OVERSTREET
-
Publication number: 20200101283Abstract: Devices, systems, and methods for specializing, monitoring, and/or evaluating therapeutic nasal neuromodulation are disclosed herein. A targeted neuromodulation system configured in accordance with embodiments of the present technology can include, for example, an evaluation/modulation assembly at a distal portion of a shaft and including a plurality of electrodes. The electrodes are configured to emit stimulating energy at frequencies for identifying and locating target neural structures and detect the resultant bioelectric properties of the tissue. The system can also include a console that maps locations of the target neural structures. The evaluation/modulation assembly can then apply therapeutic neuromodulation energy in a highly tailored neuromodulation pattern based on the mapped locations of the target neural structures. Accordingly, the system provides therapeutic neuromodulation to highly specific target structures while avoiding non-target structures to reduce collateral effects.Type: ApplicationFiled: November 26, 2019Publication date: April 2, 2020Inventors: David Townley, Brian Shields, Ivan Keogh, Peter Dockery, Ian Stephen O'Brien, Martin O'Halloran, Emily Elizabeth Porter, Marggie Jones
-
Publication number: 20200101284Abstract: This document discusses, among other things, systems and methods for programming neuromodulation therapy to treat neurological or cardiovascular diseases. A system includes an input circuit that receives a modulation magnitude representing a level of stimulation intensity, a memory that stores a plurality of gain functions associated with a plurality of modulation parameters, and a electrostimulator that may generate and deliver an electrostimulation therapy. A controller may program the electrostimulator with the plurality of modulation parameters based on the received modulation magnitude and the plurality of gain functions, and control the electrostimulator to generate electrostimulation therapy according to the plurality of modulation parameters.Type: ApplicationFiled: August 30, 2019Publication date: April 2, 2020Inventors: Goran N. Marnfeldt, Michael A. Moffitt
-
Publication number: 20200101285Abstract: A medical electrical lead and methods of implanting medical electrical leads in lumens. Leads in accordance with the invention employ preformed biases to stabilize the lead within a lumen and to orient electrodes in a preferred orientation.Type: ApplicationFiled: November 20, 2019Publication date: April 2, 2020Inventors: Randy W. Westlund, Mark C. Lynn
-
Publication number: 20200101286Abstract: Ketoacidosis is a medical emergency that requires swift intervention to avert life-threatening sequel. A body-worn sensor (50) configured to measure the levels of a ketone compound circulating in a physiological fluid of a wearer and capable of generating an alert to the wearer if the level of the circulating ketone compound exceeds a pre-defined level or rate of change is disclosed herein. The sensor (50) preferably includes at least one of an electrochemical sensor, an optical sensor, a galvanic sensor, a voltammetric sensor, an amperometric sensor, a potentiometric sensor, an impedimetric sensor, a resistive sensor, a capacitive sensor, an ultrasonic sensor, a radio-frequency sensor, or a microwave sensor.Type: ApplicationFiled: December 3, 2019Publication date: April 2, 2020Applicant: Biolinq, Inc.Inventors: Joshua Windmiller, Jared Rylan Tangney, Thomas Arnold Peyser, John Sjolund
-
Publication number: 20200101287Abstract: An electro-acupuncture (EA) system and method for performing EA on a patient are provided. The EA system comprises a wearable neurostimulator device, at least a first pair of electrically-conductive acupuncture needles and a system controller. The wearable neurostimulator device comprises a casing, an EA circuit mechanically coupled to the casing, and an attachment device mechanically coupled to the casing and adapted to removably secure the wearable neurostimulator device to the patient. The first pair of electrically-conductive acupuncture needles is mechanically coupled to the casing and electrically coupled to the EA circuit. The system controller is in communication with the EA circuit of the wearable neurostimulator device via a communication link and controls the EA circuit to cause the EA circuit to output an output voltage selected by the system controller at a frequency selected by the system controller.Type: ApplicationFiled: September 27, 2019Publication date: April 2, 2020Inventors: Jin-Woo Choi, Jose Aquiles Parodi Amaya, Ronald Koh
-
Publication number: 20200101288Abstract: Presented herein are techniques for time interleaving the sampling of input signals with the delivery of stimulation signals to a recipient of an implantable electrically-stimulating hearing prosthesis. The input signals, which are received via one or more input channels and sampled by a sound processing unit, are susceptible to electrical feedback from the stimulation signals. As such, in accordance with embodiments presented herein, the sampling of the input signals by the sound processing unit, and the delivery of the stimulation signals to the recipient, are synchronized with one another so as to avoid stimulation-evoked electrical feedback within the input signals.Type: ApplicationFiled: December 4, 2019Publication date: April 2, 2020Inventor: Koen Van den Heuvel
-
Publication number: 20200101289Abstract: Described here are devices and methods for increasing ocular mucin and other tear protein release using intranasally delivered electrical stimulation. Generally, the devices may deliver electrical stimulation to the nasal mucosa. Intranasal stimulation may trigger degranulation of conjunctival goblet cells, which in turn releases secretory mucins into the tear fluid. The intranasal stimulation may also trigger release of lysozyme, lactoferrin, and other tear proteins into the aqueous layer of the tear film. The methods may further comprise obtaining feedback relating to the efficacy of the delivered electrical stimulation by measuring impedance or an electromyogram (EMG) signal.Type: ApplicationFiled: September 5, 2019Publication date: April 2, 2020Inventors: James Donald Loudin, Manfred Franke, Douglas Michael Ackermann
-
Publication number: 20200101290Abstract: Illustrative methods and devices for providing stimulus to the eye to treat vision disorders. Systems and methods for feedback relating to the stimulus itself as well as the effect of such stimulus on the patient are provided. Various examples may include therapies for vision disorders that can progress to blindness, such as macular degeneration or other diseases and disease processes.Type: ApplicationFiled: October 1, 2019Publication date: April 2, 2020Applicant: BIOVISICS MEDICAL, LLCInventors: PAUL ROCKLEY, THOMAS W. HAROLD, JAMES R. CHIAPETTA
-
Publication number: 20200101291Abstract: Systems, devices, and methods for neurostimulation using a combination of implantable and external devices to treat pain are disclosed.Type: ApplicationFiled: May 10, 2019Publication date: April 2, 2020Inventors: Anatoly YAKOVLEV, David PIVONKA, Logan PALMER
-
Publication number: 20200101292Abstract: A method of facilitating therapeutic neuromodulation of a heart of a patient includes positioning an electrode in a pulmonary artery, positioning a sensor in vasculature, delivering via a stimulation system first and second electrical signals of a series of electrical signals to the electrode. The second electrical signal differs from the first electrical signal by a magnitude of a first parameter of a plurality of parameters. The method includes determining, via the sensor, sensor data indicative of one or more heart activity properties in response to the delivery of the series of electrical signals, and delivering a therapeutic neuromodulation signal to the pulmonary artery using selected electrical parameters. The selected electrical parameters include a selected magnitude of the first parameter. The selected magnitude of the first parameter is based at least partially on the sensor data. The therapeutic neuromodulation signal increases heart contractility.Type: ApplicationFiled: December 2, 2019Publication date: April 2, 2020Inventors: Steven L. Waldhauser, Steven D. Goedeke
-
Publication number: 20200101293Abstract: Methods are disclosed for treating a subject having a disease or disorder comprising stimulating a nerve of the subject with a corrective stimulus pattern derived from a disease-specific, condition-specific, endogenous mediator-specific or pharmacologic agent-specific neurogram in an amount and manner effective to treat the disease or disorder.Type: ApplicationFiled: November 26, 2019Publication date: April 2, 2020Applicant: THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCHInventors: Kevin J. Tracey, Sangeeta S. Chavan
-
Publication number: 20200101294Abstract: The techniques of the disclosure describe example medical devices, systems, and methods for interleaving a plurality of low-frequency electrical stimulation pulse trains delivered by a plurality of sets of electrodes of an implantable medical device (IMD) to effectively deliver a combined high-frequency electrical pulse train to a target tissue area. In one example, each set of the plurality of sets of electrodes has a unique anode and cathode. In another example, a clinician adjusts the size or shape of the target tissue area receiving the combined high-frequency electrical pulse train by selecting different combinations of the plurality of sets of electrodes.Type: ApplicationFiled: November 21, 2019Publication date: April 2, 2020Inventor: Nathan A. Torgerson
-
Publication number: 20200101295Abstract: Brugada syndrome and related forms of ion channelopathies, including ventricular asynchrony of contraction, originate in the region near the His bundle or para-Hisian regions of the heart. Manifestations of Brugada syndrome can be corrected by delivering endocardial electrical stimulation coincident to the activation wave front propagated from the atrioventricular (AV) node early enough to compensate for the conduction problems that start in those region. The stimulation can include waveforms of the same or different polarity delivered to a site within the region near the His bundle or para-Hisian regions of the heart associated with a low cardiac electrical asynchrony level or can include at least two single-phased superimposed waveforms of opposite polarity delivered through a pair of pacing electrodes relative to a reference electrode, which can be delivered to any site within the region near the His bundle or para-Hisian regions of the heart.Type: ApplicationFiled: December 2, 2019Publication date: April 2, 2020Inventors: Daniel Felipe Ortega, Luis Dante Barja
-
Publication number: 20200101296Abstract: There is provided a method for controlling the movement of bile and/or gall stones in the biliary duct. The method comprises gently constricting (i.e., without substantially hampering the blood circulation in the tissue wall) at least one portion of the tissue wall to influence the movement of bile and/or gallstones in the biliary duct, and stimulating the constricted wall portion to cause contraction of the wall portion to further influence the movement of bile and/or gallstones in the biliary duct. The method can be used for restricting or stopping the movement of bile and/or gallstones in the biliary duct, or for actively moving the fluid in the biliary duct, with a low risk of injuring the biliary duct.Type: ApplicationFiled: September 9, 2019Publication date: April 2, 2020Inventor: Peter Forsell
-
Publication number: 20200101297Abstract: An intracardiac ventricular pacemaker includes a pulse generator for delivering ventricular pacing pulses, an impedance sensing circuit, and a control circuit in communication with the pulse generator and the impedance sensing circuit. The pacemaker is configured to produce an intraventricular impedance signal, detect an atrial systolic event using the intraventricular impedance signal, set an atrioventricular pacing interval in response to detecting the atrial systolic event, and deliver a ventricular pacing pulse in response to the atrioventricular pacing interval expiring.Type: ApplicationFiled: September 30, 2019Publication date: April 2, 2020Inventors: Ronald A. DRAKE, Melissa G.T. CHRISTIE, Kathryn HILPISCH, Bushan K. PURUSHOTHAMAN, William SCHINDELDECKER
-
Publication number: 20200101298Abstract: An implantable medical device (IMD) automatically determines at least a portion of the parameters and, in some instances all of the parameters, of an exposure operating mode based on stored information regarding sensed physiological events or therapy provided over a predetermined period of time. The IMD may configure itself to operate in accordance with the automatically determined parameters of the exposure operating mode in response to detecting a disruptive energy field. Alternatively, the IMD may provide the automatically determined parameters of the exposure operating mode to a physician as suggested or recommended parameters for the exposure operating mode. In other instances, the automatically determined parameters may be compared to parameters received manually via telemetry and, if differences exist or occur, a physician or patient may be notified and/or the manual parameters may be overridden by the automatically determined parameters.Type: ApplicationFiled: November 27, 2019Publication date: April 2, 2020Inventors: Michael L. ELLINGSON, Hyun J. YOON
-
Publication number: 20200101299Abstract: An implantable medical device (402) includes an attachment member (424) having an aperture (428) with a first diameter. A delivery device (400) includes a catheter shaft (406), a tube (450?) within the shaft, and a tether (422?) within the tube. The tube has a main portion (455?) with a second diameter and an expandable distal end (457?). The tether has a body (423?) and a tether member (426?) having a third diameter greater than the second diameter and smaller than the first diameter. The tether is slideable relative to the tube from a released condition in which the tether member is positioned at least partially distal to the distal end of the tube, and a locked condition in which the tether member is at least partially surrounded by the distal end of the tube. The distal end of the tube can pass through the aperture only in the released condition.Type: ApplicationFiled: June 20, 2018Publication date: April 2, 2020Applicant: St. Jude Medical, Cardiology Division, Inc.Inventors: Bernhard Arnar, Steven N. Willard
-
Publication number: 20200101300Abstract: Devices and methods are provided for a leadless implantable medical device (LIMD) comprising a housing. An electrode is disposed on the housing. An electronics circuit is disposed in the housing and is configured to sense cardiac signals, and/or generate and deliver pacing signals to the electrode. A transceiver circuit is disposed in the housing, and is configured to communicate wirelessly with an external device. A fixation antenna electrically separate from the electrode is disposed on a distal portion of the housing and is electrically coupled to the transceiver circuit, and configured to operate as an antenna for communication between the transceiver circuit and the external device.Type: ApplicationFiled: December 4, 2019Publication date: April 2, 2020Inventors: Perry Li, Brett Villavicencio
-
Publication number: 20200101301Abstract: An implantable device that (a) has an analog input configured to detect analog electrical signals and (b) is configured to accept RF commands can be retrofitted to prevent unauthorized access by modifying the software of the implantable device to (1) accept control commands that arrive via the analog input and (2) ignore control commands that arrive via the RF transceiver. Ultrasound communications can then be detected and inductively coupled onto a lead that is connected to the analog input. In some embodiments, the modified implantable device can only be controlled via ultrasound signals at all times to improve security. In other embodiments, the modified implantable device can only be controlled via non-ultrasound signals (e.g., RF signals) for short periods of time after the system has been unlocked in response to receipt of a specific ultrasound signal.Type: ApplicationFiled: April 5, 2018Publication date: April 2, 2020Inventor: Yoram PALTI
-
Publication number: 20200101302Abstract: A system may be used with a medical imaging system and a programming system. The medical imaging system may be configured to display a medical image and the programming system may be configured to implement a program used in programming a neuromodulation device. The system may comprise a mobile device having at least one processor, a camera and a user interface including a display. The mobile device may be configured to acquire a displayed medical image from the medical imaging system, determine based on the acquired medical image location data indicative of the position of at least one of the electrodes relative to at least one of the anatomy or at least another one of the electrodes, and provide the location data for use by the program implemented by the programming system.Type: ApplicationFiled: September 11, 2019Publication date: April 2, 2020Inventors: Ismael Huertas Fernandez, Matthew Lee McDonald, Amarpreet Singh Bains, Anirudh Joshi
-
Publication number: 20200101303Abstract: Patient support apparatuses, such as beds, cots, stretchers, chairs, or the like, include wireless communication systems that are adapted to communicate with a non-local wireless receiver positioned outside of the healthcare facility and not associated with the healthcare facility. A computer positioned within the healthcare facility and coupled a local area network of the healthcare facility receives messages from the patient support apparatuses that have been forwarded by the non-local wireless receiver to the local area network. In some embodiments, the wireless receiver is local and positioned within the healthcare facility. In such instances, a second computer, such as a server, forwards a first subset of the patient support apparatus messages to a first computer via the local area network and a second subset of the patient support apparatus messages to a device remote from the healthcare facility. Patient support apparatuses that communicate using visible light are also disclosed.Type: ApplicationFiled: December 2, 2019Publication date: April 2, 2020Inventor: Michael Joseph Hayes
-
Publication number: 20200101304Abstract: An implantable medical device having a package, including: a device body, and a package configured for packaging the device body. The package includes at least one organic film layer and at least one inorganic film layer that are stacked on one another. An innermost layer of the package is an organic film layer or an inorganic film layer, and an outermost layer of the package is an organic film layer or an inorganic film layer. Each organic film layer is a parylene film or polyimide resin film with biocompatibility, and each inorganic film layer is an inorganic film with biocompatibility. A method for packaging an implantable medical device is also provided.Type: ApplicationFiled: July 21, 2017Publication date: April 2, 2020Applicant: SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGYInventors: Tianzhun WU, Saisai ZHAO, Ye FENG, Chunlei YANG
-
Publication number: 20200101305Abstract: A fixation device for use with an implantable medical device includes a body member comprising a contact surface shaped to conform to an outer surface of the implantable medical device, an adhesion element provided on a contact surface of the body member and configured to attach the body member to the outer surface of the implantable medical device, and an anchor member extending from the body member and having a hole for securing the fixation device to a human body while the body member is attached to the outer surface of the implantable medical device.Type: ApplicationFiled: September 28, 2018Publication date: April 2, 2020Inventors: James George Elcoate Smith, Sung Jin Lee, Mark B. Downing
-
Publication number: 20200101306Abstract: An ambulatory medical device is provided. The device includes battery lock circuitry configured to transmit a lock signal at a beginning of a battery lock period of the ambulatory medical device and transmit an unlock signal upon detecting an unlock triggering event indicating an end of the battery lock period of the ambulatory medical device. The device also includes a battery being configured to be securely disposed within a chamber of the ambulatory medical device in a first locked manner and provide power to the ambulatory medical device and a battery lock configured to mechanically engage the battery in a second locked manner upon receiving the lock signal indicating the beginning of the battery lock period of the ambulatory medical device and mechanically disengage the battery from the second locked manner upon receiving the unlock signal signaling the end of the battery lock period.Type: ApplicationFiled: September 28, 2018Publication date: April 2, 2020Applicant: ZOLL MEDICAL CORPORATIONInventors: Mark F. Roberto, John Clark
-
Publication number: 20200101307Abstract: Devices and methods for generating and applying stimulated acupuncture needles to one or more acupuncture points on a body of an individual suffering from one or more ailments using magnetic fields. The acupuncture device is configured for generating magnetic fields to stimulate acupuncture without using human manual manipulation. The acupuncture device may comprise a control unit and one or more acupuncture needle stimulation units. Each one or more acupuncture needle stimulation unit is functionally connected to the control unit by a cable or lead. The control unit may include a variable frequency generator configured to deliver various power levels, direct voltages, or a combination of various power levels and direct voltages to the acupuncture needle stimulation units, alone or in combination with other stimuli.Type: ApplicationFiled: September 27, 2019Publication date: April 2, 2020Inventors: Dennis Marcantonio, Greg Bartosiewicz
-
Publication number: 20200101308Abstract: The invention relates to a transcranial magnetic stimulation device comprising: at least two coils (130, 140), an input channel (150, 160) for each coil (130, 40), a control unit (170), at least one energy storage (120) for storing energy for the at least two coils (130, 140), the control unit (170) is configured to: determine at least one stimulus intensity; determine an energy level stored in the at least one energy storage (120); determine a modulation pattern for each coil (130, 140); generate at least one control signal for controlling the input channel of the at least one coil (130, 140) of the at least two coils (130, 140) according to the determined modulation pattern in order to control an input of each coil (130, 140) from the at least one energy storage (120). A method is also disclosed.Type: ApplicationFiled: April 3, 2018Publication date: April 2, 2020Inventors: Risto ILMONIEMI, Jaakko NIEMINEN, Lari KOPONEN
-
Publication number: 20200101309Abstract: A magnetic field generating-apparatus for biostimulation including: a C-shaped annular core having a gap-portion; and coils wound around the core, wherein the core includes a pair of facing extended-portions which lie on the both sides of the gap-portion and which face to each other by extending toward the adjacent directions, and includes a pair of opposite-side portions which are juxtaposed on the respective outsides of the pair of facing extended-portions, and wherein the coils are wound around the pair of opposite-side portions respectively.Type: ApplicationFiled: September 10, 2019Publication date: April 2, 2020Inventor: Mitsugu KAWARAI
-
Publication number: 20200101310Abstract: The present disclosure is directed to compositions, devices, a system, and related methods for treatment of skin. The subject matter of the present disclosure also provides maintenance treatment, acne treatment, rejuvenation treatment, and anti-aging treatment for skin. In accordance with some aspects, a photodynamic skin therapy system may generally comprise an apparatus supporting light emissive panels which may in some situations be configured and operative to be coupled to a remote or external device. The light emissive panels may emit light of a selected wavelength in accordance with instructions defining a skin treatment regimen.Type: ApplicationFiled: April 30, 2018Publication date: April 2, 2020Inventors: Ellen Marmur, Alison Cutlan, Edward Gilchrest, Nam Thanh Le, Matt Prancuk
-
Publication number: 20200101311Abstract: This disclosure relates to an intra-oral phototherapy device, comprising: a handle; at least one mouthpiece removably connectable to the handle; and at least one light source in the mouthpiece adapted to direct light inside a mouth of a user. It will be apparent that the device described herein has broad applications.Type: ApplicationFiled: May 25, 2018Publication date: April 2, 2020Inventor: Masoud TAHGHIGHI JAFARZADEH
-
Publication number: 20200101312Abstract: Disclosures of the present invention describe a phototherapy device mainly comprises a phototherapeutic host and a patch module having a connection base, wherein the patch module can be assembled with the phototherapeutic host by letting the connection base be connected with the base through an interlocking mechanism, a rotary locking mechanism or a magnetic lock mechanism. In addition, the phototherapeutic host can be attached to and detached from the patch module. Briefly speaking, this phototherapy device has advantages of simple structure, small volume, being portable, being easy to be operated, and having patch units that are replaceable. In addition, the phototherapeutic host is designed to have a modular structure comprising a base, a PCB, a lighting unit, and a cover, such that the phototherapeutic host can be manufactured and/or used individually.Type: ApplicationFiled: July 30, 2019Publication date: April 2, 2020Inventors: JUIFEN PAI, CHEN PING KUO
-
Publication number: 20200101313Abstract: A phototherapy device includes a light source module configured to emit therapeutic light to an affected area of a skin. The light source module includes a plurality of LED elements to emit light having a peak wavelength in a range of 365 nm±5 nm, and having a wavelength equal to or shorter than 350 nm. The light source module also includes a light outlet window to which the light emitted from the LED elements is incident and through which the therapeutic light exits. The light source module also includes a filter configured to substantially shield light having a wavelength equal to or shorter than 350 nm when the light emitted from the LED elements passes through the filter.Type: ApplicationFiled: September 25, 2019Publication date: April 2, 2020Applicants: PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY, Ushio Denki Kabushiki KaishaInventors: Akimichi MORITA, Hideyuki MASUDA, Makoto KIMURA
-
Publication number: 20200101314Abstract: An optical therapeutic device comprising a front body portion, a light source provided in said front body portion, a spherical, translucent quartz lens provided in front of said light source, a bezel provided on said front body portion and configured to hold said spherical, translucent quartz lens such that a portion of the quartz lens protrudes outside the rim of the bezel. Also described is a method of using the device to apply light stimulation to acupuncture points of a human or animal body and a method for manufacturing the device.Type: ApplicationFiled: March 6, 2018Publication date: April 2, 2020Inventor: Jan Fredrik SOLBERG
-
Publication number: 20200101315Abstract: A bacteria removal laser is provided, especially for removing caries bacteria from natural or prosthetic teeth, the prosthetic teeth also being treated via extraoral approach, having a gripping handle, a laser radiation source, an application optics having a predetermined radiation exit surface, especially a radiation guide rod through which laser radiation passes, and an energy source such as a mains connection or an accumulator. The laser emits in the wavelength range between 2200 nm and 4000 nm and is especially designed as an Er:YAG laser. The energy output averaged over time is less than 1 mJ/mm2 at the radiation exit surface.Type: ApplicationFiled: September 20, 2019Publication date: April 2, 2020Inventor: Jonas Reinhardt